サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1239995

エクソソーム研究用製品の世界市場 - 業界動向と予測（～2030年）

Global Exosome Research Products Market - Industry Trends And Forecast To 2030
出版日: | 発行: Data Bridge Market Research | ページ情報: 英文 498 Pages | 納期: お問合せ

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エクソソーム研究用製品の世界市場 - 業界動向と予測（～2030年）
出版日: 2023年01月02日
発行: Data Bridge Market Research
ページ情報: 英文 498 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のエクソソーム研究用製品の市場規模は、2023年～2030年の予測期間に35.6%というかなりのCAGRを記録すると予測されます。

市場の成長を促進する要因としては、がんや慢性炎症、自己免疫疾患、ライム病、その他の慢性変性疾患の有病率の増加、医薬品の研究開発およびライフサイエンス研究への投資の増加が挙げられます。

当レポートでは、世界のエクソソーム研究用製品市場を調査し、市場の促進要因や抑制要因、機会や課題、セグメント・地域別の市場内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

  • PESTEL分析
  • ポーターのファイブフォースモデル
  • サプライチェーン分析
  • バリューチェーン分析
  • 事業戦略の優秀性
  • ケーススタディ
  • 製品ポートフォリオの強み
  • 技術動向
  • 価格分析

第5章 業界考察

第6章 世界のエクソソーム研究用製品市場：規制

第7章 市場概要

  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第8章 世界のエクソソーム研究用製品市場：製品別

  • 概要
  • 消耗品
    • キット・試薬
    • エクソソームスタンダード
    • エクソソーム抗体
    • 細胞株
    • 免疫プレート
    • 免疫ビーズ
    • 生体液
    • その他
  • 機器
    • 卓上型
    • 独立型

第9章 世界のエクソソーム研究用製品市場：適応症別

  • 概要
  • がん
    • 肺がん
    • 乳がん
    • 結腸直腸がん
    • 前立腺がん
    • その他のがん
  • がん以外
    • 循環器疾患
    • 神経変性疾患
    • 感染症
    • その他

第10章 世界のエクソソーム研究用製品市場：用途別

  • 概要
  • 治療
  • 消耗品
  • 機器
  • 診断
  • 消耗品

第11章 世界のエクソソーム研究用製品市場：エンドユーザー別

  • 概要
  • 製薬・バイオテクノロジー企業
  • 研究センター
  • 学術機関
  • 臨床検査室
  • 病院
  • その他

第12章 世界のエクソソーム研究用製品市場：流通チャネル別

  • 概要
  • 第三者販売業者
  • 直販
  • オンライン

第13章 世界のエクソソーム研究用製品市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • スイス
    • オランダ
    • トルコ
    • スウェーデン
    • ポーランド
    • ノルウェー
    • ベルギー
    • フィンランド
    • デンマーク
    • その他欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • シンガポール
    • マレーシア
    • タイ
    • インドネシア
    • フィリピン
    • ニュージーランド
    • ベトナム
    • 台湾
    • その他アジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • 中東・アフリカ
    • 南アフリカ
    • エジプト
    • サウジアラビア
    • アラブ首長国連邦
    • バーレーン
    • クウェート
    • オマーン
    • カタール
    • その他中東・アフリカ

第14章 世界のエクソソーム研究用製品市場：企業情勢

  • 企業シェア分析：世界
  • 企業シェア分析：北米
  • 企業シェア分析：欧州
  • 企業シェア分析：アジア太平洋地域

第15章 SWOT分析

第16章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • EXODX（BIO-TECHNEによって買収）
  • MILTENYI BIOTEC
  • LUMINEX CORPORATION
  • HOLOGIC, INC.
  • AETHLON MEDICAL, INC.（2022）
  • AGILENT TECHNOLOGIES, INC.
  • AMSBI0
  • AUDUBON BIOSCIENCE.
  • BECKMAN COULTER, INC
  • BIOVISION INC.（ABCAM PLCによって買収）
  • CELL GUIDANCE SYSTEMS LLC
  • CREATIVE BIOARRAY
  • CUSABIO TECHNOLOGY LLC
  • FUJIFILM IRVINE SCIENTIFIC（FUJIFILM HOLDINGS CORPORATIONの子会社）
  • HBMLS（LONZAによって買収）
  • HITACHI, LTD.
図表
  • 16.18 INOVIQ 480
    • 16.18.1 COMPANY SNAPSHOT 480
    • 16.18.2 REVENUE ANALYSIS 480
    • 16.18.3 PRODUCT PORTFOLIO 481
    • 16.18.4 RECENT DEVELOPMENT 481
  • 16.19 JSR MICRO NV 482
    • 16.19.1 COMPANY SNAPSHOT 482
    • 16.19.2 PRODUCT PORTFOLIO 482
    • 16.19.3 RECENT DEVELOPMENT 482
  • 16.20 MICROGENTAS 483
    • 16.20.1 COMPANY SNAPSHOT 483
    • 16.20.2 PRODUCT PORTFOLIO 483
    • 16.20.3 RECENT DEVELOPMENTS 483
  • 16.21 NANOSOMIX 484
    • 16.21.1 COMPANY SNAPSHOT 484
    • 16.21.2 PRODUCT PORTFOLIO 484
    • 16.21.3 RECENT DEVELOPMENT 484
  • 16.22 NEXOSOME-ONCOLOGY 485
    • 16.22.1 COMPANY SNAPSHOT 485
    • 16.22.2 PRODUCT PORTFOLIO 485
    • 16.22.3 RECENT DEVELOPMENTS 485
  • 16.23 NORGEN BIOTEK CORP. 486
    • 16.23.1 COMPANY SNAPSHOT 486
    • 16.23.2 PRODUCT PORTFOLIO 486
    • 16.23.3 RECENT DEVELOPMENTS 486
  • 16.24 NOVUS BIOLOGICALS 487
    • 16.24.1 COMPANY SNAPSHOT 487
    • 16.24.2 PRODUCT PORTFOLIO 487
    • 16.24.3 RECENT DEVELOPMENT 488
  • 16.25 PROTEOGENEX 489
    • 16.25.1 COMPANY SNAPSHOT 489
    • 16.25.2 PRODUCT PORTFOLIO 489
    • 16.25.3 RECENT DEVELOPMENT 489
  • 16.26 QIAGEN 490
    • 16.26.1 COMPANY SNAPSHOT 490
    • 16.26.2 REVENUE ANALYSIS 490
    • 16.26.3 PRODUCT PORTFOLIO 491
    • 16.26.4 RECENT DEVELOPMENT 491
  • 16.27 ROOSTERBIO, INC. 492
    • 16.27.1 COMPANY SNAPSHOT 492
    • 16.27.2 PRODUCT PORTFOLIO 492
    • 16.27.3 RECENT DEVELOPMENTS 493
  • 16.28 SYSTEM BIOSCIENCES, LLC. 494
    • 16.28.1 COMPANY SNAPSHOT 494
    • 16.28.2 PRODUCT PORTFOLIO 494
    • 16.28.3 RECENT DEVELOPMENT 494

17 QUESTIONNAIRE 495

18 RELATED REPORTS 498

LIST OF TABLES

  • TABLE 1 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, PRICING ANALYSIS 88
  • TABLE 2 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT , 2021-2030 (USD THOUSAND) 103
  • TABLE 3 GLOBAL CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 104
  • TABLE 4 GLOBAL CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 105
  • TABLE 5 GLOBAL KITS AND REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 105
  • TABLE 6 GLOBAL INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 108
  • TABLE 7 GLOBAL INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 108
  • TABLE 8 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 112
  • TABLE 9 GLOBAL CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 114
  • TABLE 10 GLOBAL CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 114
  • TABLE 11 GLOBAL NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 115
  • TABLE 12 GLOBAL NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 116
  • TABLE 13 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 120
  • TABLE 14 GLOBAL THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 121
  • TABLE 15 GLOBAL THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
  • TABLE 16 GLOBAL DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 122
  • TABLE 17 GLOBAL DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 123
  • TABLE 18 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 127
  • TABLE 19 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 128
  • TABLE 20 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 128
  • TABLE 21 GLOBAL RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 129
  • TABLE 22 GLOBAL RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 130
  • TABLE 23 GLOBAL ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 131
  • TABLE 24 GLOBAL ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 131
  • TABLE 25 GLOBAL CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 132
  • TABLE 26 GLOBAL CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 132
  • TABLE 27 GLOBAL HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 133
  • TABLE 28 GLOBAL HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 2021-2030 (USD THOUSAND) 133
  • TABLE 29 GLOBAL OTHERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 134
  • TABLE 30 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 138
  • TABLE 31 GLOBAL THIRD PARTY DISTRIBUTORS IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 139
  • TABLE 32 GLOBAL DIRECT SALES IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 140
  • TABLE 33 GLOBAL ONLINE IN EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 140
  • TABLE 34 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY REGION, 2021-2030 (USD THOUSAND) 146
  • TABLE 35 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 151
  • TABLE 36 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 151
  • TABLE 37 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 151
  • TABLE 38 NORTH AMERICA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 152
  • TABLE 39 NORTH AMERICA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 152
  • TABLE 40 NORTH AMERICA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 153
  • TABLE 41 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 153
  • TABLE 42 NORTH AMERICA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 153
  • TABLE 43 NORTH AMERICA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 154
  • TABLE 44 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 154
  • TABLE 45 NORTH AMERICA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 154
  • TABLE 46 NORTH AMERICA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 154
  • TABLE 47 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 155
  • TABLE 48 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 155
  • TABLE 49 NORTH AMERICA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 155
  • TABLE 50 NORTH AMERICA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 156
  • TABLE 51 NORTH AMERICA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 156
  • TABLE 52 NORTH AMERICA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 156
  • TABLE 53 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 156
  • TABLE 54 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
  • TABLE 55 U.S. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 157
  • TABLE 56 U.S. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 158
  • TABLE 57 U.S. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 158
  • TABLE 58 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 158
  • TABLE 59 U.S. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 159
  • TABLE 60 U.S. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 159
  • TABLE 61 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 159
  • TABLE 62 U.S. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 160
  • TABLE 63 U.S. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 160
  • TABLE 64 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 160
  • TABLE 65 U.S. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
  • TABLE 66 U.S. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
  • TABLE 67 U.S. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
  • TABLE 68 U.S. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 161
  • TABLE 69 U.S. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 162
  • TABLE 70 U.S. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 162
  • TABLE 71 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 163
  • TABLE 72 CANADA CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 163
  • TABLE 73 CANADA KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 164
  • TABLE 74 CANADA INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 164
  • TABLE 75 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 164
  • TABLE 76 CANADA CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 165
  • TABLE 77 CANADA NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 165
  • TABLE 78 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 165
  • TABLE 79 CANADA THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 166
  • TABLE 80 CANADA DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 166
  • TABLE 81 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 166
  • TABLE 82 CANADA PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
  • TABLE 83 CANADA RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
  • TABLE 84 CANADA ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
  • TABLE 85 CANADA CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 167
  • TABLE 86 CANADA HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 168
  • TABLE 87 CANADA EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 168
  • TABLE 88 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 169
  • TABLE 89 MEXICO CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 169
  • TABLE 90 MEXICO KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 170
  • TABLE 91 MEXICO INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 170
  • TABLE 92 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 170
  • TABLE 93 MEXICO CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 171
  • TABLE 94 MEXICO NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 171
  • TABLE 95 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 171
  • TABLE 96 MEXICO THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
  • TABLE 97 MEXICO DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 172
  • TABLE 98 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 172
  • TABLE 99 MEXICO PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
  • TABLE 100 MEXICO RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
  • TABLE 101 MEXICO ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
  • TABLE 102 MEXICO CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 173
  • TABLE 103 MEXICO HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 174
  • TABLE 104 MEXICO EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 174
  • TABLE 105 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 180
  • TABLE 106 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 180
  • TABLE 107 EUROPE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 181
  • TABLE 108 EUROPE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 181
  • TABLE 109 EUROPE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 182
  • TABLE 110 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 182
  • TABLE 111 EUROPE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 182
  • TABLE 112 EUROPE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 183
  • TABLE 113 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 183
  • TABLE 114 EUROPE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 183
  • TABLE 115 EUROPE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 183
  • TABLE 116 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 184
  • TABLE 117 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 184
  • TABLE 118 EUROPE RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 184
  • TABLE 119 EUROPE ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
  • TABLE 120 EUROPE CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
  • TABLE 121 EUROPE HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 185
  • TABLE 122 EUROPE EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 185
  • TABLE 123 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 186
  • TABLE 124 GERMANY CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 186
  • TABLE 125 GERMANY KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 187
  • TABLE 126 GERMANY INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 187
  • TABLE 127 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 187
  • TABLE 128 GERMANY CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 188
  • TABLE 129 GERMANY NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 188
  • TABLE 130 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 188
  • TABLE 131 GERMANY THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 189
  • TABLE 132 GERMANY DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 189
  • TABLE 133 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 189
  • TABLE 134 GERMANY PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 190
  • TABLE 135 GERMANY RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 190
  • TABLE 136 GERMANY ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 190
  • TABLE 137 GERMANY CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 190
  • TABLE 138 GERMANY HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 191
  • TABLE 139 GERMANY EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 191
  • TABLE 140 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 192
  • TABLE 141 U.K. CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 192
  • TABLE 142 U.K. KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 193
  • TABLE 143 U.K. INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 193
  • TABLE 144 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 193
  • TABLE 145 U.K. CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 194
  • TABLE 146 U.K. NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 194
  • TABLE 147 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 194
  • TABLE 148 U.K. THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 195
  • TABLE 149 U.K. DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 195
  • TABLE 150 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 195
  • TABLE 151 U.K. PHARMACEUTICAL & BIOTECHNOLOGY COMPANY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 196
  • TABLE 152 U.K. RESEARCH CENTERS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 196
  • TABLE 153 U.K. ACADEMIC INSTITUTES IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 196
  • TABLE 154 U.K. CLINICAL TESTING LABORATORY IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 196
  • TABLE 155 U.K. HOSPITALS IN EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 197
  • TABLE 156 U.K. EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 197
  • TABLE 157 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 198
  • TABLE 158 FRANCE CONSUMABLES IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 198
  • TABLE 159 FRANCE KITS & REAGENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 199
  • TABLE 160 FRANCE INSTRUMENTS IN EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND) 199
  • TABLE 161 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 199
  • TABLE 162 FRANCE CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 200
  • TABLE 163 FRANCE NON-CANCER IN EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION, 2021-2030 (USD THOUSAND) 200
  • TABLE 164 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 200
  • TABLE 165 FRANCE THERAPEUTICS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 201
  • TABLE 166 FRANCE DIAGNOSIS IN EXOSOME RESEARCH PRODUCTS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 201
  • TABLE 167 FRANCE EXOSOME RESEARCH PRODUCTS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 201

LIST OF FIGURES

  • FIGURE 1 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 59
  • FIGURE 2 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: DATA TRIANGULATION 62
  • FIGURE 3 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: DROC ANALYSIS 63
  • FIGURE 4 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 64
  • FIGURE 5 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: COMPANY RESEARCH ANALYSIS 64
  • FIGURE 6 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: INTERVIEW DEMOGRAPHICS 67
  • FIGURE 7 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: DBMR MARKET POSITION GRID 68
  • FIGURE 8 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: MARKET APPLICATION COVERAGE GRID 70
  • FIGURE 9 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: VENDOR SHARE ANALYSIS 71
  • FIGURE 10 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: SEGMENTATION 74
  • FIGURE 11 THE INCREASE IN THE PREVALENCE OF CANCER AND OTHER AUTO-IMMUNE DISEASE IS EXPECTED TO DRIVE THE GLOBAL EXOSOME RESEARCH PRODUCTS MARKET GROWTH IN THE FORECAST PERIOD 75
  • FIGURE 12 THE CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL EXOSOME RESEARCH PRODUCTS MARKET IN 2023 & 2030 75
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 76
  • FIGURE 14 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR GLOBAL EXOSOME RESEARCH PRODUCTS MARKET MANUFACTURERS IN THE FORECAST PERIOD 77
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL EXOSOME RESEARCH PRODUCTS MARKET 93
  • FIGURE 16 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2022 101
  • FIGURE 17 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, 2023-2030 (USD THOUSAND) 102
  • FIGURE 18 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, CAGR (2023-2030) 102
  • FIGURE 19 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT, LIFELINE CURVE 103
  • FIGURE 20 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2022 110
  • FIGURE 21 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, 2023-2030 (USD THOUSAND) 111
  • FIGURE 22 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, CAGR (2023-2030) 111
  • FIGURE 23 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY INDICATION, LIFELINE CURVE 112
  • FIGURE 24 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2022 118
  • FIGURE 25 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 119
  • FIGURE 26 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, CAGR (2023-2030) 119
  • FIGURE 27 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION, LIFELINE CURVE 120
  • FIGURE 28 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2022 125
  • FIGURE 29 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 126
  • FIGURE 30 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, CAGR (2023-2030) 126
  • FIGURE 31 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY END USER, LIFELINE CURVE 127
  • FIGURE 32 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2022 136
  • FIGURE 33 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 137
  • FIGURE 34 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 137
  • FIGURE 35 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 138
  • FIGURE 36 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 143
  • FIGURE 37 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY REGION (2022) 144
  • FIGURE 38 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY REGION (2023 & 2030) 144
  • FIGURE 39 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY REGION (2022 & 2030) 145
  • FIGURE 40 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT TYPE (2023-2030) 145
  • FIGURE 41 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 148
  • FIGURE 42 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 149
  • FIGURE 43 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 149
  • FIGURE 44 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 150
  • FIGURE 45 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 150
  • FIGURE 46 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 176
  • FIGURE 47 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 177
  • FIGURE 48 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 177
  • FIGURE 49 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 178
  • FIGURE 50 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 179
  • FIGURE 51 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 278
  • FIGURE 52 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 279
  • FIGURE 53 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 279
  • FIGURE 54 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 280
  • FIGURE 55 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 280
  • FIGURE 56 SOUTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 367
  • FIGURE 57 SOUTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 368
  • FIGURE 58 SOUTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 368
  • FIGURE 59 SOUTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 369
  • FIGURE 60 SOUTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: BY PRODUCT (2023-2030) 369
  • FIGURE 61 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: SNAPSHOT (2022) 390
  • FIGURE 62 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022) 391
  • FIGURE 63 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2023 & 2030) 391
  • FIGURE 64 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: BY COUNTRY (2022 & 2030) 392
  • FIGURE 65 MIDDLE EAST AND AFRICA EXOSOME RESEARCH PRODUCTS MARKET: PRODUCT (2023-2030) 392
  • FIGURE 66 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 447
  • FIGURE 67 NORTH AMERICA EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 448
  • FIGURE 68 EUROPE EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 449
  • FIGURE 69 ASIA-PACIFIC EXOSOME RESEARCH PRODUCTS MARKET: COMPANY SHARE 2022 (%) 450
目次

Global exosome research products market is projected to register a substantial CAGR of 35.6% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation: Global Exosome Research Products Market By Product (Instruments, and Consumables), Indication (Cancer and Non-Cancer), Application (Therapeutics and Diagnosis), End Users (Hospitals, Clinical Testing Laboratories, Research Centers, Pharmaceutical and Biotechnology Company, Academic Institutes, and Others), Distribution Channel (Third Party Distributors, Online, Direct Tender, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Arica) Industry Trends and Forecast to 2030

Market Drivers: Growing prevalence of cancer, chronic inflammation, autoimmune disease, Lyme disease, and other chronic degenerative diseases Increasing investments in pharmaceutical R&D and life sciences research Market Players: The key market players in global exosome research products market are listed below:

Hologic Inc.

Luminex Corporation

Thermo Fisher Scientific

Agilent Technologies, Inc.

RoosterBio, Inc.

Microgentas

Cell Guidance Systems LLC

QIAGEN

FUJIFILM Irvine Scientific( a subsidiary of FUJIFILM Holdings Corporation)

CUSABIO TECHNOLOGY LLC

NEXOSOME-ONCOLOGY

Norgen Biotek Corp.

Miltenyi Biotec

Aethlon Medical, Inc.,

System Biosciences, LLC.

AMSBIO

ExoDx (Acquired By Bio-Techne)

BioVision Inc. (Acquired By Abcam plc)

HBMLS (Acquired by Lonza)

Creative Bioarray

NanoSomiX

Novus Biologicals

Beckman Coulter, Inc.

JSR Micro NV

Hitachi, Ltd.

INOVIQ

ProteoGenex

Audubon Bioscience

TABLE OF CONTENTS

1 INTRODUCTION 54

  • 1.1 OBJECTIVES OF THE STUDY 54
  • 1.2 MARKET DEFINITION 54
  • 1.3 OVERVIEW OF THE GLOBAL EXOSOME RESEARCH PRODUCTS MARKET 54
  • 1.4 LIMITATIONS 56
  • 1.5 MARKETS COVERED 56

2 MARKET SEGMENTATION 59

  • 2.1 MARKETS COVERED 59
  • 2.2 GEOGRAPHICAL SCOPE 60
  • 2.3 YEARS CONSIDERED FOR THE STUDY 61
  • 2.4 CURRENCY AND PRICING 61
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
  • 2.6 MULTIVARIATE MODELLING 65
  • 2.7 PRODUCT LIFELINE CURVE 66
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 67
  • 2.9 DBMR MARKET POSITION GRID 68
  • 2.10 MARKET APPLICATION COVERAGE GRID 70
  • 2.11 VENDOR SHARE ANALYSIS 71
  • 2.12 SECONDARY SOURCES 72
  • 2.13 ASSUMPTIONS 72

3 EXECUTIVE SUMMARY 73

4 PREMIUM INSIGHTS 75

  • 4.1 PESTEL ANALYSIS 78
  • 4.2 PORTER'S FIVE FORCES MODEL 79
  • 4.3 SUPPLY CHAIN ANALYSIS 80
  • 4.4 VALUE CHAIN ANALYSIS 81
  • 4.5 BUSINESS STRATEGY EXCELLENCE 82
  • 4.6 CASE STUDIES 83
  • 4.7 STRENGTH OF PRODUCT PORTFOLIO 85
  • 4.8 TECHNOLOGICAL TRENDS 87
  • 4.9 PRICING ANALYSIS 88

5 INDUSTRY INSIGHTS 89

6 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, REGULATIONS 90

7 MARKET OVERVIEW 92

  • 7.1 DRIVERS 94
    • 7.1.1 GROWING PREVALENCE OF CANCER, CHRONIC INFLAMMATION, AUTOIMMUNE DISEASE, LYME DISEASE, AND OTHER CHRONIC DEGENERATIVE DISEASES 94
    • 7.1.2 INCREASING INVESTMENTS IN PHARMACEUTICAL R&D AND LIFE SCIENCES RESEARCH 94
    • 7.1.3 AVAILABILITY OF VARIOUS EXOSOME ISOLATION AND PURIFICATION TECHNIQUES AND PROGRESSING THERAPEUTIC VALUE OF EXOSOME 95
  • 7.2 RESTRAINTS 96
    • 7.2.1 LACK OF GOLD STANDARD PROTOCOLS FOR THE DEVELOPMENT AND PRODUCTION OF EXOSOMES 96
    • 7.2.2 THE SHORTAGE OF SKILLED PROFESSIONALS REQUIRED FOR THE ISOLATION OF EXOSOME 96
  • 7.3 OPPORTUNITIES 97
    • 7.3.1 RISING DEMAND FOR SPECIALIZED TESTING SERVICES AMONG END USERS. 97
    • 7.3.2 INCREASING ADVANCEMENT IN EXOSOME TECHNOLOGY 97
    • 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 98
  • 7.4 CHALLENGES 99
    • 7.4.1 SIDE EFFECTS ASSOCIATED WITH EXOSOME RESEARCH PRODUCTS 99
    • 7.4.2 LATE APPROVAL ASSOCIATED WITH PRODUCT LAUNCHES 99

8 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY PRODUCT 100

  • 8.1 OVERVIEW 101
  • 8.2 CONSUMABLES 104
    • 8.2.1 KITS AND REAGENTS 105
      • 8.2.1.1 EXOSOME BIOMARKER KITS 106
      • 8.2.1.2 EXOSOME ISOLATION KITS 106
      • 8.2.1.3 EXOSOME PURIFICATION KITS 106
      • 8.2.1.4 EXOSOME QUANTITATIVE KITS 106
      • 8.2.1.5 EXOSOME DETECTION KITS 106
      • 8.2.1.6 OTHERS 106
    • 8.2.2 EXOSOME STANDARDS 106
    • 8.2.3 EXOSOME ANTIBODIES 106
    • 8.2.4 CELL LINES 106
    • 8.2.5 IMMUNOPLATES 107
    • 8.2.6 IMMUNOBEADS 107
    • 8.2.7 BIOFLUIDS 107
    • 8.2.8 OTHERS 107
  • 8.3 INSTRUMENTS 107
    • 8.3.1 BENCHTOP 108
    • 8.3.2 STANDALONE 108

9 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY INDICATION 109

  • 9.1 OVERVIEW 110
  • 9.2 CANCER 113
    • 9.2.1 LUNG CANCER 114
    • 9.2.2 BREAST CANCER 114
    • 9.2.3 COLORECTAL CANCER 114
    • 9.2.4 PROSTATE CANCER 115
    • 9.2.5 OTHER CANCER 115
  • 9.3 NON-CANCER 115
    • 9.3.1 CARDIOVASCULAR DISEASE 116
    • 9.3.2 NEURODEGENERATIVE DISEASE 116
    • 9.3.3 INFECTIOUS DISEASE 116
    • 9.3.4 OTHERS 116

10 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET: BY APPLICATION 117

  • 10.1 OVERVIEW 118
  • 10.2 THERAPEUTICS 121
  • 10.3 CONSUMABLES 122
  • 10.4 INSTRUMENTS 122
  • 10.5 DIAGNOSIS 122
  • 10.6 CONSUMABLES 123
  • 10.7 INSTRUMENTS 123

11 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY END USER 124

  • 11.1 OVERVIEW 125
  • 11.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANY 128
  • 11.3 CONSUMABLES 129
  • 11.4 INSTRUMENTS 129
  • 11.5 RESEARCH CENTRES 129
  • 11.6 CONSUMABLES 130
  • 11.7 INSTRUMENTS 130
  • 11.8 ACADEMIC INSTITUTES 130
  • 11.9 CONSUMABLES 131
  • 11.10 INSTRUMENTS 131
  • 11.11 CLINICAL TESTING LABORATORY 131
  • 11.12 CONSUMABLES 132
  • 11.13 INSTRUMENTS 132
  • 11.14 HOSPITALS 133
  • 11.15 CONSUMABLES 134
  • 11.16 INSTRUMENTS 134
  • 11.17 OTHERS 134

12 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL 135

  • 12.1 OVERVIEW 136
  • 12.2 THIRD PARTY DISTRIBUTORS 139
  • 12.3 DIRECT SALES 139
  • 12.4 ONLINE 140

13 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, BY REGION 141

  • 13.1 OVERVIEW 142
  • 13.2 NORTH AMERICA 147
    • 13.2.1 U.S. 157
    • 13.2.2 CANADA 163
    • 13.2.3 MEXICO 169
  • 13.3 EUROPE 175
    • 13.3.1 GERMANY 186
    • 13.3.2 U.K. 192
    • 13.3.3 FRANCE 198
    • 13.3.4 ITALY 204
    • 13.3.5 SPAIN 210
    • 13.3.6 RUSSIA 216
    • 13.3.7 SWITZERLAND 222
    • 13.3.8 NETHERLANDS 228
    • 13.3.9 TURKEY 234
    • 13.3.10 SWEDEN 240
    • 13.3.11 POLAND 246
    • 13.3.12 NORWAY 252
    • 13.3.13 BELGIUM 258
    • 13.3.14 FINLAND 264
    • 13.3.15 DENMARK 270
    • 13.3.16 REST OF EUROPE 276
  • 13.4 ASIA-PACIFIC 277
    • 13.4.1 CHINA 287
    • 13.4.2 JAPAN 293
    • 13.4.3 INDIA 299
    • 13.4.4 SOUTH KOREA 305
    • 13.4.5 AUSTRALIA 311
    • 13.4.6 SINGAPORE 317
    • 13.4.7 MALAYSIA 323
    • 13.4.8 THAILAND 329
    • 13.4.9 INDONESIA 335
    • 13.4.10 PHILIPPINES 341
    • 13.4.11 NEW ZEALAND 347
    • 13.4.12 VIETNAM 353
    • 13.4.13 TAIWAN 359
    • 13.4.14 REST OF ASIA-PACIFIC 365
  • 13.5 SOUTH AMERICA 366
    • 13.5.1 BRAZIL 376
    • 13.5.2 ARGENTINA 382
    • 13.5.3 REST OF SOUTH AMERICA 388
  • 13.6 MIDDLE EAST AND AFRICA 389
    • 13.6.1 SOUTH AFRICA 399
    • 13.6.2 EGYPT 405
    • 13.6.3 SAUDI ARABIA 411
    • 13.6.4 U.A.E 417
    • 13.6.5 BAHARAIN 422
    • 13.6.6 KUWAIT 428
    • 13.6.7 OMAN 434
    • 13.6.8 QATAR 440
    • 13.6.9 MIDDLE EAST AND AFRICA 446

14 GLOBAL EXOSOME RESEARCH PRODUCTS MARKET, COMPANY LANDSCAPE 447

  • 14.1 COMPANY SHARE ANALYSIS: GLOBAL 447
  • 14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 448
  • 14.3 COMPANY SHARE ANALYSIS: EUROPE 449
  • 14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 450

15 SWOT ANALYSIS 451

16 COMPANY PROFILE 452

  • 16.1 THERMO FISHER SCIENTIFIC INC. 452
    • 16.1.1 COMPANY SNAPSHOT 452
    • 16.1.2 REVENUE ANALYSIS 452
    • 16.1.3 COMPANY SHARE ANALYSIS 453
    • 16.1.4 PRODUCT PORTFOLIO 453
    • 16.1.5 RECENT DEVELOPMENT 454
  • 16.2 EXODX (ACQUIRED BY BIO-TECHNE) 455
    • 16.2.1 COMPANY SNAPSHOT 455
    • 16.2.2 REVENUE ANALYSIS 455
    • 16.2.3 COMPANY SHARE ANALYSIS 456
    • 16.2.4 PRODUCT PORTFOLIO 456
    • 16.2.5 RECENT DEVELOPMENT 456
  • 16.3 MILTENYI BIOTEC 457
    • 16.3.1 COMPANY SNAPSHOT 457
    • 16.3.2 COMPANY SHARE ANALYSIS 457
    • 16.3.3 PRODUCT PORTFOLIO 458
    • 16.3.4 RECENT DEVELOPMENTS 458
  • 16.4 LUMINEX CORPORATION 459
    • 16.4.1 COMPANY SNAPSHOT 459
    • 16.4.2 PRODUCT PORTFOLIO 459
    • 16.4.3 RECENT DEVELOPMENT 459
  • 16.5 HOLOGIC, INC. 460
    • 16.5.1 COMPANY SNAPSHOT 460
    • 16.5.2 REVENUE ANALYSIS 460
    • 16.5.3 COMPANY SHARE ANALYSIS 461
    • 16.5.4 PRODUCT PORTFOLIO 461
    • 16.5.5 RECENT DEVELOPMENTS 461
  • 16.6 AETHLON MEDICAL, INC. (2022) 462
    • 16.6.1 COMPANY SNAPSHOT 462
    • 16.6.2 PRODUCT PORTFOLIO 463
    • 16.6.3 RECENT DEVELOPMENTS 463
  • 16.7 AGILENT TECHNOLOGIES, INC. 464
    • 16.7.1 COMPANY SNAPSHOT 464
    • 16.7.2 REVENUE ANALYSIS 464
    • 16.7.3 PRODUCT PORTFOLIO 465
    • 16.7.4 RECENT DEVELOPMENT 465
  • 16.8 AMSBI0 466
    • 16.8.1 COMPANY SNAPSHOT 466
    • 16.8.2 PRODUCT PORTFOLIO 466
    • 16.8.3 RECENT DEVELOPMENT 466
  • 16.9 AUDUBON BIOSCIENCE. 467
    • 16.9.1 COMPANY SNAPSHOT 467
    • 16.9.2 PRODUCT PORTFOLIO 467
    • 16.9.3 RECENT DEVELOPMENT 467
  • 16.10 BECKMAN COULTER, INC 468
    • 16.10.1 COMPANY SNAPSHOT 468
    • 16.10.2 PRODUCT PORTFOLIO 468
    • 16.10.3 RECENT DEVELOPMENT 468
  • 16.11 BIOVISION INC. (ACQUIRED BY ABCAM PLC) 469
    • 16.11.1 COMPANY SNAPSHOT 469
    • 16.11.2 REVENUE ANALYSIS 469
    • 16.11.3 COMPANY SHARE ANALYSIS 470
    • 16.11.4 PRODUCT PORTFOLIO 470
    • 16.11.5 RECENT DEVELOPMENT 470
  • 16.12 CELL GUIDANCE SYSTEMS LLC 471
    • 16.12.1 COMPANY SNAPSHOT 471
    • 16.12.2 PRODUCT PORTFOLIO 471
    • 16.12.3 RECENT DEVELOPMENTS 471
  • 16.13 CREATIVE BIOARRAY 472
    • 16.13.1 COMPANY SNAPSHOT 472
    • 16.13.2 PRODUCT PORTFOLIO 472
    • 16.13.3 RECENT DEVELOPMENT 472
  • 16.14 CUSABIO TECHNOLOGY LLC 473
    • 16.14.1 COMPANY SNAPSHOT 473
    • 16.14.2 PRODUCT PORTFOLIO 473
    • 16.14.3 RECENT DEVELOPMENTS 473
  • 16.15 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION 474
    • 16.15.1 COMPANY SNAPSHOT 474
    • 16.15.2 REVENUE ANALYSIS 474
    • 16.15.3 PRODUCT PORTFOLIO 475
    • 16.15.4 RECENT DEVELOPMENT 475
  • 16.16 HBMLS (ACQUIRED BY LONZA) 476
    • 16.16.1 COMPANY SNAPSHOT 476
    • 16.16.2 REVENUE ANALYSIS 476
    • 16.16.3 PRODUCT PORTFOLIO 477
    • 16.16.4 RECENT DEVELOPMENT 477
  • 16.17 HITACHI, LTD. 478
    • 16.17.1 COMPANY SNAPSHOT 478
    • 16.17.2 REVENUE ANALYSIS 478
    • 16.17.3 PRODUCT PORTFOLIO 479
    • 16.17.4 RECENT DEVELOPMENT 479